Comparison of Cisatracurium and Vecuronium by Infusion in Neonates and Small Infants after Congenital Heart Surgery
Authors:
- 1 November 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 101 (5) , 1122-1127
Abstract
Background: Neonates and infants often require extended periods of mechanical ventilation facilitated by sedation and neuromuscular blockade. Methods: Twenty-three patients aged younger than 2 yr were randomly assigned to receive either cisatracurium or vecuronium infusions postoperatively in a double-blinded fashion after undergoing congenital heart surgery. The infusion was titrated to maintain one twitch of a train-of-four. The times to full spontaneous recovery of train-of-four without fade, extubation, intensive care unit discharge, and hospital discharge were documented after drug discontinuation. Sparse sampling after termination of the infusion and a one-compartment model were used for pharmacokinetic analysis. The Mann-Whitney U test and Student t test were used to compare data between groups. Results: There were no significant differences between groups with respect to demographic data or duration of postoperative neuromuscular blockade infusion. The median recovery time for train-of-four for cisatracurium (30 min) was less than that for vecuronium (180 min) (P < 0.05). Three patients in the vecuronium group had prolonged train-of-four recovery: Two had long elimination half-lives for vecuronium, and one had a high concentration of 3-OH vecuronium. There were no differences in extubation times, intensive care unit stays, or hospital stays between groups. Conclusions: Our results parallel data from adults demonstrating a markedly shorter recovery of neuromuscular transmission after cisatracurium compared with vecuronium. Decreased clearance of vecuronium and the accumulation of 3-OH vecuronium may contribute to prolonged spontaneous recovery times. Cisatracurium is associated with faster spontaneous recovery of neuromuscular function compared with vecuronium but not with any differences in intermediate outcome measures in neonates and infants.Keywords
This publication has 19 references indexed in Scilit:
- Do the pharmacokinetics of vecuronium change during prolonged administration in critically ill patients?British Journal of Anaesthesia, 1998
- A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R‐ cis 1′R‐ cis isomer of atracurium, with atracurium besylate in healthy patientsAnaesthesia, 1997
- Importance of the Organ-Independent Elimination of CisatracuriumAnesthesia & Analgesia, 1996
- The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patientsIntensive Care Medicine, 1996
- Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unitBritish Journal of Anaesthesia, 1996
- Pharmacodynamics and Pharmacokinetics of Cisatracurium in Geriatric Surgical PatientsAnesthesiology, 1996
- Persistent Paralysis in Critically Ill Patients after Long-Term Administration of VecuroniumNew England Journal of Medicine, 1992
- The Pharmacodynamics and Pharmacokinetics of Vecuronium in Patients Anesthetized with Isoflurane with Normal Renal Function or with Renal FailureAnesthesiology, 1988
- HEPATOBILIARY DISPOSITION OF VECURONIUM BROMIDE IN MANBritish Journal of Anaesthesia, 1986
- Pharmacokinetics and Pharmacodynamics of Vecuronium (ORG NC 45) in Patients with CirrhosisAnesthesiology, 1985